Annual Cash & Cash Equivalents
$14.11 M
-$3.33 M-19.09%
31 December 2023
Summary:
InflaRx NV annual cash & cash equivalents is currently $14.11 million, with the most recent change of -$3.33 million (-19.09%) on 31 December 2023. During the last 3 years, it has fallen by -$17.83 million (-55.81%). IFRX annual cash & cash equivalents is now -90.46% below its all-time high of $147.90 million, reached on 31 December 2017.IFRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$29.27 M
+$8.74 M+42.57%
01 September 2024
Summary:
InflaRx NV quarterly cash and cash equivalents is currently $29.27 million, with the most recent change of +$8.74 million (+42.57%) on 01 September 2024. Over the past year, it has increased by +$6.30 million (+27.45%). IFRX quarterly cash and cash equivalents is now -83.78% below its all-time high of $180.45 million, reached on 30 June 2018.IFRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IFRX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.1% | +27.4% |
| 3 y3 years | -55.8% | -63.9% |
| 5 y5 years | -77.7% | -0.9% |
IFRX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.8% | at low | -63.9% | +1179.9% |
| 5 y | 5 years | -77.7% | at low | -68.3% | +1179.9% |
| alltime | all time | -90.5% | +290.9% | -83.8% | +1179.9% |
InflaRx NV Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.27 M(+42.6%) |
| June 2024 | - | $20.53 M(-24.3%) |
| Mar 2024 | - | $27.11 M(+92.1%) |
| Dec 2023 | $14.11 M(-19.1%) | $14.11 M(-38.5%) |
| Sept 2023 | - | $22.96 M(+8.3%) |
| June 2023 | - | $21.21 M(+827.4%) |
| Mar 2023 | - | $2.29 M(-86.9%) |
| Dec 2022 | $17.44 M(-41.3%) | $17.44 M(-1.3%) |
| Sept 2022 | - | $17.67 M(+9.7%) |
| June 2022 | - | $16.10 M(-64.0%) |
| Mar 2022 | - | $44.75 M(+50.6%) |
| Dec 2021 | $29.72 M(-6.9%) | $29.72 M(-63.4%) |
| Sept 2021 | - | $81.16 M(-5.8%) |
| June 2021 | - | $86.11 M(-6.7%) |
| Mar 2021 | - | $92.30 M(+189.0%) |
| Dec 2020 | $31.94 M | $31.94 M(-39.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $52.64 M(+28.6%) |
| June 2020 | - | $40.94 M(+76.0%) |
| Mar 2020 | - | $23.25 M(-37.3%) |
| Dec 2019 | $37.11 M(-41.4%) | $37.11 M(+25.6%) |
| Sept 2019 | - | $29.55 M(-51.9%) |
| June 2019 | - | $61.47 M(+16.1%) |
| Mar 2019 | - | $52.97 M(-16.4%) |
| Dec 2018 | $63.36 M(-57.2%) | $63.36 M(-3.2%) |
| Sept 2018 | - | $65.48 M(-63.7%) |
| June 2018 | - | $180.45 M(+27.0%) |
| Mar 2018 | - | $142.08 M(-3.9%) |
| Dec 2017 | $147.90 M(+380.5%) | $147.90 M(+468.4%) |
| Sept 2017 | - | $26.02 M(-10.2%) |
| June 2017 | - | $28.98 M(-5.9%) |
| Dec 2016 | $30.78 M(+752.6%) | $30.78 M |
| Dec 2015 | $3.61 M | - |
FAQ
- What is InflaRx NV annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for InflaRx NV?
- What is InflaRx NV annual cash & cash equivalents year-on-year change?
- What is InflaRx NV quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for InflaRx NV?
- What is InflaRx NV quarterly cash and cash equivalents year-on-year change?
What is InflaRx NV annual cash & cash equivalents?
The current annual cash & cash equivalents of IFRX is $14.11 M
What is the all time high annual cash & cash equivalents for InflaRx NV?
InflaRx NV all-time high annual cash & cash equivalents is $147.90 M
What is InflaRx NV annual cash & cash equivalents year-on-year change?
Over the past year, IFRX annual cash & cash equivalents has changed by -$3.33 M (-19.09%)
What is InflaRx NV quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IFRX is $29.27 M
What is the all time high quarterly cash and cash equivalents for InflaRx NV?
InflaRx NV all-time high quarterly cash and cash equivalents is $180.45 M
What is InflaRx NV quarterly cash and cash equivalents year-on-year change?
Over the past year, IFRX quarterly cash and cash equivalents has changed by +$6.30 M (+27.45%)